Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review

Despite being rare, the Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a serious, possibly fatal condition that may affect both adults and children who may be also burdened by delayed sequelae. It is an adverse drug reaction characterized by widespread skin involvement, fever,...

Full description

Bibliographic Details
Main Authors: Elisa Manieri, Arianna Dondi, Iria Neri, Marcello Lanari
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1108345/full
_version_ 1827891157685764096
author Elisa Manieri
Arianna Dondi
Iria Neri
Marcello Lanari
author_facet Elisa Manieri
Arianna Dondi
Iria Neri
Marcello Lanari
author_sort Elisa Manieri
collection DOAJ
description Despite being rare, the Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a serious, possibly fatal condition that may affect both adults and children who may be also burdened by delayed sequelae. It is an adverse drug reaction characterized by widespread skin involvement, fever, lymphadenopathy, visceral involvement, and laboratory abnormalities (eosinophilia, mononucleosis-like atypical lymphocytes). It is more frequently triggered by anticonvulsants, sulphonamides, or antibiotics, the latter being responsible for up to 30% of pediatric cases. The disease typically develops 2–8 weeks after exposure to the culprit medication, with fever and widespread skin eruption; mild viral prodromes are possible. Unfortunately, diagnosis is challenging due to the absence of a reliable test; however, a score by the European Registry of Severe Cutaneous Adverse Reactions (RegiSCAR) allows to classify suspect patients into no, possible, probable, or definite DRESS cases. Moreover, rapid-onset DRESS syndrome has been described in recent years. It affects children more often than adults and differs from the most common form because it appears ≤15 days vs. >15 days after starting the drug, it is usually triggered by antibiotics or iodinated contrast media rather than by anticonvulsants and has a higher presence of lymphadenopathy. Differential diagnosis between rapid-onset antibiotic-driven DRESS syndrome, viral exanthems, or other drug eruptions may be challenging, but it is mandatory to define it as early as possible to start adequate treatment and monitor possible complications. The present review reports the latest evidence about the diagnosis and treatment of pediatric DRESS syndrome.
first_indexed 2024-03-12T21:20:51Z
format Article
id doaj.art-6015c4d3aca14106a3b184b3caa89e8c
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-03-12T21:20:51Z
publishDate 2023-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-6015c4d3aca14106a3b184b3caa89e8c2023-07-28T19:17:26ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-07-011010.3389/fmed.2023.11083451108345Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative reviewElisa Manieri0Arianna Dondi1Iria Neri2Marcello Lanari3Specialty School of Pediatrics, Alma Mater Studiorum, University of Bologna, Bologna, ItalyPediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalyDivision of Dermatology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalyPediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, ItalyDespite being rare, the Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a serious, possibly fatal condition that may affect both adults and children who may be also burdened by delayed sequelae. It is an adverse drug reaction characterized by widespread skin involvement, fever, lymphadenopathy, visceral involvement, and laboratory abnormalities (eosinophilia, mononucleosis-like atypical lymphocytes). It is more frequently triggered by anticonvulsants, sulphonamides, or antibiotics, the latter being responsible for up to 30% of pediatric cases. The disease typically develops 2–8 weeks after exposure to the culprit medication, with fever and widespread skin eruption; mild viral prodromes are possible. Unfortunately, diagnosis is challenging due to the absence of a reliable test; however, a score by the European Registry of Severe Cutaneous Adverse Reactions (RegiSCAR) allows to classify suspect patients into no, possible, probable, or definite DRESS cases. Moreover, rapid-onset DRESS syndrome has been described in recent years. It affects children more often than adults and differs from the most common form because it appears ≤15 days vs. >15 days after starting the drug, it is usually triggered by antibiotics or iodinated contrast media rather than by anticonvulsants and has a higher presence of lymphadenopathy. Differential diagnosis between rapid-onset antibiotic-driven DRESS syndrome, viral exanthems, or other drug eruptions may be challenging, but it is mandatory to define it as early as possible to start adequate treatment and monitor possible complications. The present review reports the latest evidence about the diagnosis and treatment of pediatric DRESS syndrome.https://www.frontiersin.org/articles/10.3389/fmed.2023.1108345/fullchildrendrug reaction with eosinophilia and systemic symptomsDRESSdrug reactiondrug hypersensitivityantibiotics
spellingShingle Elisa Manieri
Arianna Dondi
Iria Neri
Marcello Lanari
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review
Frontiers in Medicine
children
drug reaction with eosinophilia and systemic symptoms
DRESS
drug reaction
drug hypersensitivity
antibiotics
title Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review
title_full Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review
title_fullStr Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review
title_full_unstemmed Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review
title_short Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review
title_sort drug rash with eosinophilia and systemic symptoms dress syndrome in childhood a narrative review
topic children
drug reaction with eosinophilia and systemic symptoms
DRESS
drug reaction
drug hypersensitivity
antibiotics
url https://www.frontiersin.org/articles/10.3389/fmed.2023.1108345/full
work_keys_str_mv AT elisamanieri drugrashwitheosinophiliaandsystemicsymptomsdresssyndromeinchildhoodanarrativereview
AT ariannadondi drugrashwitheosinophiliaandsystemicsymptomsdresssyndromeinchildhoodanarrativereview
AT irianeri drugrashwitheosinophiliaandsystemicsymptomsdresssyndromeinchildhoodanarrativereview
AT marcellolanari drugrashwitheosinophiliaandsystemicsymptomsdresssyndromeinchildhoodanarrativereview